Overview

Neuropeptide Treatment for Hot Flushes During the Menopause

Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
Placebo-controlled, double-blinded, cross-over clinical trial of a new investigational product
Phase:
Phase 2
Details
Lead Sponsor:
Imperial College London
Collaborators:
AstraZeneca
Medical Research Council
National Institute for Health Research, United Kingdom